Table 1. Overall demographics and clinical characteristics (n = 99).
Variable | Category | Count (%) |
---|---|---|
Age | 40–49 | 6 (6.06%) |
50–59 | 16 (16.16%) | |
60–69 | 30 (30.30%) | |
70 and over | 47 (47.47%) | |
Race | White | 68 (68.69%) |
Black/ African American | 16 (16.16%) | |
Hispanic/Latino | 12 (12.12%) | |
Other | 3 (3.03%) | |
BAC | Positive | 49 (49.49%) |
Negative | 50 (50.51%) | |
CAC | Positive | 37 (37.37%) |
Negative | 62 (62.63%) | |
ASCVD risk score * | Low risk (<5%) | 22 (25.0%) |
Borderline risk (5%-7.4%) | 7 (7.95%) | |
Intermediate risk (7.5%-19.9%) | 30 (34.09%) | |
High risk (>20%) | 29 (32.95%) | |
ASCVD risk score* (binary) | Low risk (<7.5%) | 29 (32.95%) |
Moderate–High risk (7.5%—over 20%) | 59 (67.05%) | |
MACE | Yes | 26 (26.26%) |
No | 73 (73.74%) | |
Death | Yes | 16 (16.16%) |
No | 83 (83.84%) | |
Smoking Status | Never | 57 (57.58%) |
Current | 38 (38.38%) | |
Unknown | 4 (4.04%) | |
Diabetes | Yes | 20 (20.20%) |
No | 79 (79.80%) | |
Hypertension | Yes | 58 (58.58%) |
No | 41 (41.41%) |